Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers (Q56794516)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Relationship between the CYP2C9 IVS8-109A>T polymorphism and high losartan hydroxylation in healthy Ecuadorian volunteers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Enrique Teran

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Adrián Llerena

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Adrián Llerena

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

Alicia Gallego

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Eva Peñas-LLedó

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

1 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

1417-1421

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

Four novel defective alleles and comprehensive haplotype analysis of CYP2C9 in Japanese.

21 February 2020

cites work

1 reference

A haplotype of CYP2C9 associated with warfarin sensitivity in mechanical heart valve replacement patients

21 January 2018

1 reference

Pharmacokinetics of losartan and its metabolite E-3174 in relation to the CYP2C9 genotype

21 January 2018

1 reference

Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes

21 January 2018

1 reference

Losartan hydroxylation phenotype in an Ecuadorian population: influence of CYP2C9 genetic polymorphism, habits and gender

21 January 2018

1 reference

Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.14.85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25303293%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference